Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Y-mAbs Therapeutics, Inc. (YMAB) had Receiveable Turnover of 3.78 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$84.82M |
|
$-21.43M |
|
$11.37M |
|
$73.45M |
|
$110.49M |
|
$-25.67M |
|
$4.81M |
|
$-20.87M |
|
$-20.87M |
|
$-21.43M |
|
$-21.43M |
|
$-21.43M |
|
$-21.43M |
|
$-25.67M |
|
$-24.94M |
|
43.65M |
|
43.65M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$111.11M |
|
$0.22M |
|
$16.76M |
|
$127.87M |
|
$20.13M |
|
-- |
|
$6.76M |
|
$26.88M |
|
$100.98M |
|
$98.35M |
|
$100.98M |
|
43.67M |
|
| Cash Flow Statement Financials | |
$-27.23M |
|
-- |
|
$0.10M |
|
$105.76M |
|
$78.64M |
|
$-27.12M |
|
$14.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.60% |
|
-30.27% |
|
-30.27% |
|
-29.40% |
|
-24.60% |
|
-25.26% |
|
$-27.23M |
|
-- |
|
-- |
|
-- |
|
0.66 |
|
2.24 |
|
|
Receiveable Turnover |
3.78 |
96.63 |
|
-21.22% |
|
-21.79% |
|
-16.76% |
|
-21.22% |
|
$2.31 |
|
$-0.62 |
|
$-0.62 |
|